Jazz Pharmaceuticals plc (JAZZ) › Net IncomeJazz Pharmaceuticals plc (JAZZ) — Net IncomeAnnual figures by fiscal year, from SEC filings.2009: -$6.84M2010: $32.78M2011: $124.98M2012: $288.59M2013: $216.31M2014: $58.39M2015: $329.54M2016: $396.83M2017: $487.85M2018: $447.10M2019: $523.37M2020: $238.62M2021: -$329.67M2022: -$224.06M2023: $414.83M2024: $560.12M2025: -$356.15M-$356.15M2009Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$356.15M-163.6%2024$560.12M+35.0%2023$414.83M+285.1%2022-$224.06M+32.0%2021-$329.67M-238.2%2020$238.62M-54.4%2019$523.37M+17.1%2018$447.10M-8.4%2017$487.85M+22.9%2016$396.83M+20.4%2015$329.54M+464.4%2014$58.39M-73.0%2013$216.31M-25.0%2012$288.59M+130.9%2011$124.98M+281.3%2010$32.78M+579.5%2009-$6.84M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share